THIAMINE HYDROCHLORIDE- thiamine hydrochloride injection 
Neogen Corporation - Nandino

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Thiamine Hydrochloride
500mg/mL 
Sterile Solution

Indications:

For use as a supplemental source of thiamine in dogs, cats, and horses.

Each mL Contains:

Thiamine Hydrochloride..........................500 mg

Disodium Edetate..............................0.01% w/v

Benzyle Alcohol (as preservative)..........1.5% v/v

Water for Injection......................................q.s.

pH adjusted with Hydrochloric acid or Sodium Hydroxide

Dosage and Administration:

For intravenous or intramuscular use as determined by the veterinarian.

Warning:

Anaphylactogenesis to parental thiamine has occurred. Administer slowly and with caution in doses over 0.10 mL (50mg)

Store at controlled temperatures between 15° and 30°C (59° - 86°F). 

Manufactured by Sparhawk Laboratories, Lenexa, KS 66215

for Neogen® Corporation, Lexington, KY 40511 • 859-254-1221

Principal Display Panel

THIAMINE HYDROCHLORIDE

500 mg/mL

Sterile Solution

For use in dogs, cats and horses

Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian

FOR ANIMAL USE ONLY

KEEP OUT OF THE REACH OF CHILDREN

Net Content:100 mL

Thiamine Hydrochloride

Thiamine Hydrochloride

Thiamine Hydrochloride

THIAMINE HYDROCHLORIDE 
thiamine hydrochloride injection
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:59051-9083
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
THIAMINE HYDROCHLORIDE (UNII: M572600E5P) (THIAMINE ION - UNII:4ABT0J945J) THIAMINE HYDROCHLORIDE500 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
EDETATE DISODIUM (UNII: 7FLD91C86K) .1 mg  in 1 mL
BENZYL ALCOHOL (UNII: LKG8494WBH) .015 mL  in 1 mL
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59051-9083-5100 mL in 1 VIAL, MULTI-DOSE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/01/2000
Labeler - Neogen Corporation - Nandino (042125879)
Registrant - Sparhawk Laboratories, Inc. (147979082)
Establishment
NameAddressID/FEIBusiness Operations
Sparhawk Laboratories, Inc.147979082analysis, manufacture
Establishment
NameAddressID/FEIBusiness Operations
Jiangxi Tianxin Pharmaceutical Co., Ltd.527410270api manufacture

Revised: 12/2023
Document Id: 9dda813e-2ed3-4ad3-9da4-5b6c1425fe93
Set id: 5db35043-5b09-4d32-9603-9ce23832cbc5
Version: 2
Effective Time: 20231212
 
Neogen Corporation - Nandino